Hypoxia-induced autophagy has been suggested to mediate NSCLC chemoresistance [18]; therefore, we hypothesized that eIF5A2 might promote NSCLC chemotherapy resistance by enhancing autophagy. This evidence concerns the gene EIF5A2 and non-small cell lung carcinoma.